01
Aug 2017
Finally, An Affordable Cure for Hepatitis C
Published in News on August 01, 2017
 
                                                            You’ve probably seen the ads on television talking about Hepatitis C. The World Health Organization estimates over 71 million people globally have Hep C and that 95% of those patients can be cured using expensive antiviral medications. Now, the more than 200,000 people in Australia who suffer from Hep C might be able to afford a brand-new and effective treatment.
Health Minister Greg Hunt announces that starting August 1, the Turnbull government plans to subsidise this new drug, called Epclusa. This medication combines the antivirals sofosbuvir and velpatasvir. Because this new drug is part of the Pharmaceutical Benefits Scheme (PBS), patients can expect to pay up to $38.80 a month ($6.30 for concession patients) for this combination drug, which would normally cost over $20,000 for a single treatment.
Health Minister Hunt says that about 800 Australians die each year from Hep C and that “our investment in this drug is aimed at reversing this unacceptable statistic.”
Results from clinical trials of Epclusa show a cure rate of around 90 percent and an added benefit is that this medication can be used to treat patients with any of the Hep C genotypes. The six subtypes of Hep C make it difficult for GPs to identify and treat the correct disease.
Putting Epclusa on the PBS list makes it easier for doctors to prescribe the drug and Minister Hunt expects it to increase uptake rates, especially for patients who live in rural areas. An estimated 227,000 Australians lived with Hepatitis C in 2015.
Australia was one of the first countries to subsidise drugs for patients over the age of 18 who suffer from chronic Hepatitis C. The Kirby Institute data shows nearly 40,000 people have already taken advantage of the subsidies. The government has set aside more than $1 billion for this drug over the next 5 years.
Epclusa is the first medication considered pan-genotypic, meaning the drug is effective against all subtypes of Hepatitis C. Right now, the appropriate treatment for Hep C depends upon which genotype the patient has. Epclusa will make it easier for GPs to prescribe medication for their patients with Hep C. In most cases, treatment consists of one pill a day for 12 weeks.
The drug’s subsidies are only part of the attempt to eliminate Hep C. Other interventions include prevention, early detection of the disease, and eliminating the stigma surrounding Hep C infections; 80 percent of cases occur by sharing paraphernalia to inject drugs. Around 18 percent of the Australian people don’t even know they have the disease.
Along with the push to eliminate Hepatitis C, the federal government also funds a program through the National Immunisation Program to vaccinate again Hepatitis B. Because of this program, over 96 percent of all two-year-old children have been vaccinated.
There’s no vaccine for Hepatitis C, but the new drug Epclusa is a step in the right direction to offer a permanent cure for patients who live with the struggle of Hepatitis C. Australia hopes to eradicate Hepatitis C by the year 2020.
 
                                                                                     
                                                                                     
                                                                                     
                                                                                     
                                                                                     
                                                                                     
                                                                                     
                                                                                    ![“Surprise Noises Can Feel Like Pain”: New Airport Rule Eases Travel for Autistic Passengers Emma Beardsley once dreaded going through airport security. “I used to panic every time they made me take my headphones off at security,” she recalls. “The noise and the unpredictability can be overwhelming.” Now, thanks to a new policy allowing noise-cancelling headphones to remain on during security checks, Beardsley says she can “travel more confidently and safely.”
In Australia, one in four people lives with a disability, yet the travel system has often failed to accommodate varied needs. Autism-inclusion advocates at Aspect Autism Friendly have welcomed the government’s updated guidelines that let autistic travellers keep their noise-reducing headphones on during screening, calling it a “major step” toward more accessible air travel.
Dr Tom Tutton, head of Aspect Autism Friendly, emphasises the significance of travel in people’s lives: it connects them with family, supports work and learning, and offers new experiences. But he notes the typical airport environment can be especially intense for autistic travellers:
“Airports are busy, noisy, random and quite confusing places … you’ve got renovations, food courts, blenders, coffee grinders, trolleys clattering … and constant security announcements. It’s really, really overwhelming.”
“What might be an irritation for me is something that would absolutely destroy my colleague [who has autism]. Surprise noises of a certain tone or volume can genuinely be experienced as painful.”
Under the new policy — now published on the Australian Government’s Department of Home Affairs website — passengers who rely on noise-cancelling headphones as a disability support may request to wear them through body scanners. The headphones may undergo secondary inspection instead of being forcibly removed.
Dr Tutton describes this adjustment as small in procedure but huge in impact: it removes a key point of sensory distress at a critical moment in the journey. Aspect Autism Friendly is collaborating with airports to ensure that all security staff are informed of the change.
For many autistic travellers, headphones aren’t just optional — they are essential to navigating loud, unpredictable environments. Until now, being required to remove them during security has caused distress or even deterred travel.
Aspect Autism Friendly also works directly with airports, offering staff training, autism-friendly audits, visual stories, sensory maps, and other accommodations. Their prior collaborations include autism-friendly initiatives with Qantas. Dr Tutton notes:
“Airports have become this big focus for us of trying to make that little bit of travel easier and better.”
He advises people planning trips for travellers with disabilities to consult airport websites ahead of time. Some airports already offer quiet rooms or sensory zones — Adelaide, for instance, provides spaces where travellers can step away from the noise and regroup before boarding.
Beyond helping autistic individuals, Dr Tutton believes that more accessible airports benefit everyone. “These supports help lots of other people too,” he says. “When people are more patient, kind and supportive, the benefits flow to everyone. We all prefer environments that are well-structured, sensory-friendly, predictable and easy to navigate.”](https://c3eeedc15c0611d84c18-6d9497f165d09befa49b878e755ba3c4.ssl.cf4.rackcdn.com/photos/blogs/article-1061-1759742013.jpg) 
                                                                                    